Muscle Pharm Corp. provided earnings outlook for the full year of 2013 and 2014. For the full year of 2013, the company expects to report net revenues of approximately $110 million and loss per share of $1.44.

For the full year of 2014, the company reported that it expects to report net revenues of $150 million and earnings per share in the range of $0.20 to $0.22.